(AHMEDABAD, INDIA), January 4, 2010 – Dishman Group of Ahmedabad, India, a leading products and services provider to the pharmaceutical industry, has announced the appointment of Chris Oates to the position of Chief Operating Officer. Oates will report to Nick Green, President of the Dishman global contract research and manufacturing services (CRAMS) business.
Oates will assume responsibility for Indian and Chinese operations within the company. He will be managing the development, operation, and improvement of the systems in the two manufacturing sites in India (Bavla and Naroda) and the new Shanghai facility which is due for completion mid-2010. In addition to the units in Naroda and China, Oates will be responsible for the 9 operating units at Bavla, including a large scale high potency facility which will be inaugurated at the end of January. The new state-of-the-art high potency facility will extend CARBOGEN AMCIS’ manufacturing capacity to multi-tonne scale and will be the first of its kind to be located in Asia.
Oates’ experience combines both production and operational roles in the contract manufacturing arena. He will play a pivotal role in expanding the company’s core CRAMS business.
Oates holds a bachelor’s degree in applied chemistry from the University of Huddersfield in the UK. His expertise is built on more than 20 years working within the pharmaceutical industry. He most recently served as Managing Director of Uquifa Mexico. His previous experience includes 6 years at Avecia Pharmaceuticals in the UK where he held the position of Operations Manager and as the position of Senior Production Manager for Syngenta (Agrochemicals).
“I am looking forward to taking up this new challenge and am very excited by what I believe will be a very successful future for the company” said Oates. “Dishman can provide the full continuum of services, from process R&D to large-scale commercial manufacturing, in multiple locations around the globe. The company is ideally placed to build upon its success to date and become the industry leading CRAMS partner.”
Profile
Dishman Group (www.dishmangroup.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and commercial API manufacturing services. Dishman Group improves its customers’ businesses by providing a range of development and manufacturing solutions at locations in Europe, China and India.
CARBOGEN AMCIS AG (www.carbogen-amcis.com), owned by Dishman Pharmaceuticals and Chemicals Ltd., Ahmedabad, India, is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources.
